Insider · CIK 0001898314
Justin B. Klee
Files at AMLX (Amylyx Pharmaceuticals, Inc.). First filing Jan 8, 2025, latest Sep 14, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMLX: Amylyx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | Amylyx Pharmaceuticals, Inc. | $980k 30,464 shares | -1% | +182% from low-19% from high | |
| 57Moderate | Amylyx Pharmaceuticals, Inc. | $431k 29,975 shares | -1% | +362% from low-9% from high | |
| 48Moderate | Amylyx Pharmaceuticals, Inc. | $74k 21,490 shares | -1% | +42% from low-50% from high | |
| 40Moderate | Amylyx Pharmaceuticals, Inc. | $14k 4,595 shares | -0% | +20% from low-57% from high | |
| 46Moderate | Amylyx Pharmaceuticals, Inc. | $41k 11,855 shares | -0% | +37% from low-51% from high | |
| 38Weak | Amylyx Pharmaceuticals, Inc. | $30k 7,471 shares | -0% | +57% from low-44% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -29,025 | $32.13 | $933k | 3,614,495 | 28 d ago |
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,439 | $33.16 | $48k | 3,613,056 | 28 d ago |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -29,775 | $14.37 | $428k | 3,325,501 | Oct 2, 2025 |
| Sep 30, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -200 | $15.01 | $3,002 | 3,325,301 | Oct 2, 2025 |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -21,490 | $3.46 | $74k | 3,355,276 | Apr 2, 2025 |
| Mar 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | AGrant or award Common Stock | +180,118 | $0.00 | $0 | 3,376,766 | Mar 10, 2025 |
| Mar 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +270,177 | $0.00 | $0 | 270,177 | Mar 10, 2025 |
| Mar 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,595 | $3.15 | $14k | 3,196,648 | Mar 5, 2025 |
| Feb 5, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | MOption exercise Common Stock | +36,310 | $1.57 | $57k | 3,201,243 | Feb 6, 2025 |
| Feb 5, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | MOption exercise Stock Option (right to buy)derivative | -36,310 | $0.00 | $0 | 0 | Feb 6, 2025 |
| Feb 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -11,855 | $3.47 | $41k | 3,164,933 | Feb 5, 2025 |
| Jan 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -7,471 | $4.04 | $30k | 3,176,788 | Jan 8, 2025 |
| Nov 4, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | MOption exercise Common Stock | +63,690 | $1.57 | $100k | 3,184,259 | Nov 6, 2024 |
| Nov 4, 2024 | AMLX Amylyx Pharmaceuticals, Inc. | MOption exercise Stock Option (right to buy)derivative | -63,690 | $0.00 | $0 | 36,310 | Nov 6, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.